AdvisorShares Investments LLC Sells 973 Shares of Lam Research Corporation $LRCX

AdvisorShares Investments LLC cut its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 16.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,907 shares of the semiconductor company’s stock after selling 973 shares during the quarter. AdvisorShares Investments LLC’s holdings in Lam Research were worth $478,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Empowered Funds LLC raised its position in shares of Lam Research by 10.5% in the 1st quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock worth $13,629,000 after purchasing an additional 17,833 shares during the last quarter. Pinnacle Financial Partners Inc bought a new position in shares of Lam Research during the first quarter valued at $201,000. Cookson Peirce & Co. Inc. bought a new position in shares of Lam Research during the first quarter valued at $607,000. China Universal Asset Management Co. Ltd. lifted its holdings in shares of Lam Research by 27.1% during the first quarter. China Universal Asset Management Co. Ltd. now owns 49,505 shares of the semiconductor company’s stock valued at $3,607,000 after purchasing an additional 10,565 shares in the last quarter. Finally, Glass Wealth Management Co LLC lifted its holdings in shares of Lam Research by 8.5% during the second quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock valued at $2,810,000 after purchasing an additional 2,270 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors.

Lam Research Trading Up 0.2%

Lam Research stock opened at $161.01 on Friday. The business has a 50-day simple moving average of $127.98 and a two-hundred day simple moving average of $102.36. The company has a market cap of $202.23 billion, a P/E ratio of 35.46, a P/E/G ratio of 1.68 and a beta of 1.84. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $165.22. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were given a $0.26 dividend. The ex-dividend date was Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on LRCX. Hsbc Global Res raised Lam Research to a “hold” rating in a report on Tuesday, September 30th. Dbs Bank upped their price target on Lam Research from $119.40 to $184.20 in a report on Monday. Morgan Stanley upped their price target on Lam Research from $125.00 to $137.00 and gave the company an “equal weight” rating in a report on Thursday, October 23rd. Barclays set a $142.00 price target on Lam Research and gave the company an “equal weight” rating in a report on Monday, October 20th. Finally, Stifel Nicolaus set a $160.00 price target on Lam Research and gave the company a “buy” rating in a report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $148.54.

Insider Transactions at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Ava Harter sold 9,010 shares of the company’s stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the sale, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.